EBE Annual General Meeting 2016

Starting: 06/14/2016 12:00am - Ending: 06/14/2016 12:00am

The EBE Annual General Meeting will take place on 14 June 2016 in Brussels.
Following the statutory part of the meeting (from 16h:00 CET) we are proud to offer to all our members an opportunity for information and debate though our session dedicated to IMI – opportunities and challenges for developing Advanced Therapies (until 19h00). We would like to encourage all interested company delegated to actively participate in this session.

Watch here the live broadcast


pierre-meulien300x300 Eduardo_Bravo_sq Holger-Schmoll 100x100 Salah-DIne Chibout Roberto_Gradnik-sq
Pierre Meulien
Executive DirectorIMI
Eduardo Bravo
CEO TiGenix and incoming EBE President
Holger Schmoll
Salah-Dine Chibout
Global Head Discovery & Investigative Safety and Therapeutic Areas, Novartis Pharma
Roberto Gradnik
CEO Ixaltis and the outgoing EBE president (moderator)


Registration form 

Meeting Draft Agenda

2017-09-14T15:22:52+00:00April 12, 2017|